Intra-Abdominal Infections by Carbapenemase-Producing Enterobacteriaceae in a Surgical Unit: Counting Mortality, Stay, and Costs

被引:5
|
作者
Mora-Guzman, Ismael [1 ]
Rubio-Perez, Ines [2 ]
Domingo-Garcia, Diego [3 ]
Martin-Perez, Elena [4 ]
机构
[1] Hosp Santa Barbara, Dept Gen Surg, Puertollano, Spain
[2] Hosp Univ La Paz, Dept Gen Surg, Madrid, Spain
[3] Hosp Univ La Princesa, Dept Clin Microbiol, Madrid, Spain
[4] Hosp Univ La Princesa, Dept Gen Surg, Madrid, Spain
关键词
antimicrobial stewardship; carbapenemase-producingEnterobacteriaceae; carbapenem resistance; carbapenem-resistantEnterobacteriaceae; intra-abdominal infections; surgical infections; RESISTANT KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; ESCHERICHIA-COLI; THERAPY; DISSEMINATION; DEFINITIONS; PREDICTORS; OPTIONS;
D O I
10.1089/sur.2020.137
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background:Carbapenemase-producingEnterobacteriaceae(CPE)-related infections are a problem in public health at present, including intra-abdominal infections (IAI) and surgical populations. The aim of this study was to determine mortality and related risk factors, length of stay (LOS,) and costs for CPE-IAI in surgical patients. Patients and Methods:Review of CPE-related IAI acquired during admission in a general surgery department from January 2013 to December 2018. A mortality analysis was performed specifically in patients with CPE-IAI, and a global analysis of IAI including patients with CPE-IAI (cases) and matched patients with IAI by non-resistant bacteria (controls). Results:Forty patients with CPE-IAI were included, OXA-48-producingKlebsiella pneumoniaewas present in 85%. Global mortality rate at 30 days for CPE-IAI was 17.5%; mortality-related factors were: solid tumor (p = 0.009), metastatic disease (p = 0.005), immunodeficiency (p = 0.039), blood transfusion (p = 0.009), and septic shock (p = 0.011). Predictors related to mortality for IAI in the global analysis included age (p = 0.046), Charlson index (p = 0.036), CPE isolation (p = 0.003), and septic shock (p < 0.001). Median global LOS was 43 days (IQR 27-64) in patients with CPE-IAI, and 27 days (IQR 18-35) in controls (p < 0.001). Median global cost of admission was $31,671 (IQR 14,006-55,745) for patients with CPE-IAI and $20,306 (IQR 11,974-27,947) for controls (p = 0.064). The most relevant locations of underlying disease for CPE-IAI were: colorectal (32.5%) with 57-day LOS (IQR 34-65) and cost of $42,877 (IQR 18,780-92,607), and pancreas (25%) with 60-day LOS (IQR 32-99) and cost of $56,371 (IQR 32,590-113,979). Conclusion:Carbapenemase-producingEnterobacteriaceae-related IAI is associated with substantial mortality, LOS, and costs. Factors related to CPE-IAI mortality are solid tumor, metastatic disease, immunodeficiency, blood transfusion, and septic shock. Carbapenemase-producingEnterobacteriaceaeisolation in IAI implies higher risk of mortality.
引用
收藏
页码:266 / 273
页数:8
相关论文
共 50 条
  • [1] Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing Enterobacteriaceae in a Surgical Setting
    Mora-Guzman, Ismael
    Rubio-Perez, Ines
    Domingo-Garcia, Diego
    Martin-Perez, Elena
    SURGICAL INFECTIONS, 2021, 22 (08) : 864 - 870
  • [2] Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms
    Di Carlo, Paola
    Vitale, Francesco
    O'Suilleabhain, Criostoir
    Casuccio, Alessandra
    CURRENT INFECTIOUS DISEASE REPORTS, 2014, 16 (10)
  • [3] Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms
    Paola Di Carlo
    Francesco Vitale
    Criostóir Ó’Súilleabháin
    Alessandra Casuccio
    Current Infectious Disease Reports, 2014, 16
  • [4] Treating infections caused by carbapenemase-producing Enterobacteriaceae
    Tzouvelekis, L. S.
    Markogiannakis, A.
    Piperaki, E.
    Souli, M.
    Daikos, G. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (09) : 862 - 872
  • [5] Surgical Site Infections by Carbapenemase-Producing Enterobacteriaceae OXA-48
    Mora-Guzman, Ismael
    Rubio-Perez, Ines
    Martin-Perez, Elena
    SURGICAL INFECTIONS, 2020, 21 (05) : 473 - 473
  • [6] A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
    Gutierrez-Gutierrez, Belen
    Salamanca, Elena
    de Cueto, Marina
    Hsueh, Po-Ren
    Viale, Pierluigi
    Ramon Pano-Pardo, Jose
    Venditti, Mario
    Tumbarello, Mario
    Daikos, George
    Pintado, Vicente
    Doi, Yohei
    Francisco Tuon, Felipe
    Karaiskos, Ilias
    Machuca, Isabel
    Schwaber, Mitchell J.
    Azap, Ozlem Kurt
    Souli, Maria
    Roilides, Emmanuel
    Pournaras, Spyros
    Akova, Murat
    Perez, Federico
    Bermejo, Joaquin
    Oliver, Antonio
    Almela, Manel
    Lowman, Warren
    Almirante, Benito
    Bonomo, Robert A.
    Carmeli, Yehuda
    Paterson, David L.
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    MAYO CLINIC PROCEEDINGS, 2016, 91 (10) : 1362 - 1371
  • [7] Management of Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit
    Mootien, J. Y.
    Zahar, J-R
    REANIMATION, 2018, 27 (04): : 372 - 380
  • [8] Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae
    Salzberger, Bernd
    Faetkenheuer, Gerd
    LANCET INFECTIOUS DISEASES, 2017, 17 (10): : 1020 - 1020
  • [9] Survival Analysis of Carbapenemase-Producing Enterobacteriaceae Infections in Hospital Patients
    Clark, Ian
    Rigaut, Antoine
    Mathers, Amy
    Brown, Donald
    Barnes, Laura E.
    2016 IEEE SYSTEMS AND INFORMATION ENGINEERING DESIGN SYMPOSIUM (SIEDS), 2016, : 95 - 100
  • [10] Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit: How to Manage the Risk ?
    Zahar, J-R
    Mootien, J-Y
    Pilmis, B.
    REANIMATION, 2018, 27 (04): : 367 - 371